Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis

Molecular Medicine Reports

Volumn 4, Issue 6, 2011, Pages 1283-1288

  Lin, Jiumao ^a   Wei, Lihui ^a   Xu, Wei ^a   Hong, Zhenfeng ^a   Liu, Xianxiang ^a   Peng, Jun ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Hedyotis Diffusa Willd; Multi target agents; Traditional Chinese medicine; Tumor angiogenesis

Indexed keywords

HEDYOTIS DIFFUSA EXTRACT; MESSENGER RNA; VASCULOTROPIN A;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL; CANCER THERAPY; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HT29; CELL VIABILITY; CHINESE MEDICINE; CHORIOALLANTOIS; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RNA EXTRACTION; TUMOR ANGIOGENESIS; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CHICK EMBRYO; CHICKENS; CHORIOALLANTOIC MEMBRANE; HEDYOTIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PLANT EXTRACTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

HEDYOTIS DIFFUSA;

EID: 80053092669     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.577     Document Type: Article

References (30)

1. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
2. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
3. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1: 27-31, 1995.
4. Folkman J: Angiogenesis. Annu Rev Med 57: 1-18, 2006.
5. Cook KM and Figg WD: Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin 60: 222-243, 2010.
6. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer related inflammation. Nature 454: 436-444, 2008.
7. Whiteside TL: The tumor microenvironment and its role in promoting tumor growth. Oncogene 27: 5904-5912, 2008.
8. Jain RK: Transport of molecules in the tumor interstitium: a review. Cancer Res 47: 3039-3051, 1987.
9. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial award lecture. Cancer Res 46: 467-473, 1986.
10. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
11. Breier G and Risau W: The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol 6: 454-456, 1996. (Pubitemid 26392138)
12. Stromblad S and Cheresh DA: Integrins, angiogenesis and vascular cell survival. Chem Biol 3: 881-885, 1996. (Pubitemid 27017086)
13. Risau W: Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
14. Jain RK: Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Semin Oncol 29: 3-9, 2002.
15. Ferrara N: Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 29: 10-14, 2002.
16. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003. (Pubitemid 36749215)
17. Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, Higashino F, Mezawa F, Okada F and Ishii S: Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 6: 572-577, 2000. (Pubitemid 30111481)
18. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77: 858-863, 1996. (Pubitemid 26061277)
19. Ishigami SI, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M, Mori A, Onodera H and Imamura M: Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 78: 1379-1384, 1998.
20. Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N and Ferrara N: Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 276: 3222-3230, 2001.
21. Muñoz-Chápuli R, Quesada AR and Angel Medina M: Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61: 2224-2243, 2004. (Pubitemid 39280120)
22. Chen HX and Cleck JN: Adverse effects of anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol 6: 465-477, 2009.
23. Zangari M, Fink LM, Elice F, Zhan F, Adcock DM and Tricot GJ: Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol 27: 4865-4873, 2009.
24. Higa GM and Abraham J: Biological mechanisms of bevacizumab- associated adverse events. Expert Rev Anticancer Ther 9: 999-1007, 2009.
25. Eikesdal HP and Kalluri R: Drug resistance associated with antiangiogenesis therapy. Semin Cancer Biol 19: 310-317, 2009.
26. Gordaliza M: Natural products as leads to anticancer drugs. Clin Transl Oncol 9: 767-776, 2007.
27. Ji HF, Li XJ and Zhang HY: Natural products and drug discovery. EMBO reports 10: 194-200, 2009.
28. Zhao J, Jiang P and Zhang WD: Molecular networks for the study of TCM Pharmacology. Brief Bioinform 11: 417-430, 2009.
29. Song LR: Zhong Hua Ben Cao. Vol 61. Shanghai Science and Technology Press, Shanghai, pp433, 1999.
30. Lin JM, Chen YQ, Wei LH, Chen XZ, Xu W, Hong ZF, Sferra TJ and Peng J: Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrial-dependent pathway in human colon carcinoma cells. Int J Oncol 37: 1331-1338, 2010.